Granules India announced that the company signed an agreement with Hubei Biocause Heilen Pharmaceutical, China, for setting up of a joint venture company in China.

The company further stated that the joint venture company christened Hubei Granules Biocause Pharmaceutical Co has been registered and would now become operational. The JV Company will manufacture Ibuprofen API presently.

Source:佚名